Paulo Müller Ramos

Paulo Müller Ramos

Auto-generated profile, based on publicly available information

Paulo Müller Ramos

Department of Infectology, Dermatology, Imaging Diagnosis and Radiotherapy, Faculty of Medicine, Universidade Estadual Paulista, Botucatu, SP, Brazil

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2015 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
PDF file
PRPaulo Müller Ramos
Paulo Müller Ramos
HMHelio Miot
Helio Miot
Female Pattern Hair Loss or female androgenetic alopecia is the main cause of hair loss in adult women and has a major impact on patients' quality of life. It evolves from the progressive miniaturization of follicles that lead to a subsequent decrease of the hair density, leading to a non-scarring diffuse alopecia, with characteristic clinical, dermoscopic and histological patterns. In spite of the high frequency of the disease and the relevance of its psychological impact, its pathogenesis is not yet fully understood, being influenced by genetic, hormonal and environmental factors. In addition, response to treatment is variable. In this article, authors discuss the main clinical, epidemiological and pathophysiological aspects of female pattern hair loss.

15 May 2020 in Drug Development Research
Verified
Journal Article
Open access
PDF file
CWCarlos Gustavo Wambier
Carlos Gustavo Wambier
AGAndy Goren
Andy Goren
SVSergio Vano-Galvan
Sergio Vano-Galvan
PRPaulo Müller Ramos
Paulo Müller Ramos
AOAngelina Ossimetha
Angelina Ossimetha
JMJohn McCoy
John McCoy
In this communication, we present arguments for androgen sensitivity as a likely determinant of COVID‐19 disease severity. The androgen sensitivity model explains why males are more likely to develop severe symptoms while children are ostensibly resistant to infection. Further, the model explains the difference in COVID‐19 mortality rates among different ethnicities. Androgen sensitivity is determined by genetic variants of the androgen receptor. The androgen receptor regulates transcription of the transmembrane protease, serine 2 (TMPRSS2), which is required for SARS‐CoV‐2 infectivity. TMPRSS2 primes the Spike protein of the virus, which has two consequences: diminishing viral recognition by neutralizing antibodies and activating SARS‐CoV‐2 for virus‐cell fusion. Genetic variants that have been associated with androgenetic alopecia, prostate cancer, benign prostatic hyperplasia and polycystic ovary syndrome could be associated with host susceptibility. In addition to theoretical epidemiological and molecular mechanisms, there are reports of high rates of androgenetic alopecia of from hospitalized COVID‐19 patients due to severe symptoms. Androgen sensitivity is a likely determinant of COVID‐19 disease severity. We believe that the evidence presented in this communication warrants the initiation of trials using anti‐androgen agents.

1 January 2020 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
PRPaulo Müller Ramos
Paulo Müller Ramos
RSRodney D. Sinclair
Rodney D. Sinclair
MKMichal Kasprzak
Michal Kasprzak
HMHélio Amante Miot
Hélio Amante Miot

23 May 2023 in Anais Brasileiros de Dermatologia
Verified
Journal Article
Open access
HMHelio Miot
Helio Miot
PCPaulo Criado
Paulo Criado
CCCaio César Silva de Castro
Caio César Silva de Castro
MIMayra Ianhez
Mayra Ianhez
CTCarolina Talhari
Carolina Talhari
PRPaulo Müller Ramos
Paulo Müller Ramos
The JAK-STAT signaling pathway mediates important cellular processes such as immune response, carcinogenesis, cell differentiation, division and death. Therefore, drugs that interfere with different JAK-STAT signaling patterns have potential indications for various medical conditions. The main dermatological targets of JAK-STAT pathway inhibitors are inflammatory or autoimmune diseases such as psoriasis, vitiligo, atopic dermatitis and alopecia areata; however, several dermatoses are under investigation to expand this list of indications. As JAK-STAT pathway inhibitors should gradually occupy a relevant space in dermatological prescriptions, this review presents the main available drugs, their immunological effects, and their pharmacological characteristics, related to clinical efficacy and safety, aiming to validate the best dermatological practice.

14 June 2020 in Journal of Cosmetic Dermatology
Verified
Journal Article
Closed access
PDF file
JMJohn McCoy
John McCoy
CWCarlos Gustavo Wambier
Carlos Gustavo Wambier
SVSergio Vano‐Galvan
Sergio Vano‐Galvan
JSJerry Shapiro
Jerry Shapiro
RSRodney Sinclair
Rodney Sinclair
AGAndy Goren
Andy Goren

1 March 2021 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
PRPaulo Müller Ramos
Paulo Müller Ramos
AAAlessandra Anzai
Alessandra Anzai
BDBruna Duque-Estrada
Bruna Duque-Estrada
DFDebora Cadore Farias
Debora Cadore Farias
DMDaniel Fernandes Melo
Daniel Fernandes Melo
HMHélio Amante Miot
Hélio Amante Miot